Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
Dengyuan Liu, Peng Wu, Wentao Gu, Cuihong Yang, Xinmeng Yang, Xingyu Deng, Jun Xu, Jingmei Jiang, Chengyu Jiang
Topics & Concepts
TelmisartanCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakPharmacologyAngiotensin receptorSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineAngiotensin IIReceptorVirologyOutbreakBlood pressureDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 and Mental Health